GCI adds Seattle network engineering experts to its team through Northpoint acquisition

Press Releases |

Acquisition of Seattle tech firm to strengthen expertise in networking, cloud integration and unified communication

SEATTLE, Jan. 11, 2017 /PRNewswire/ -- GCI (NASDAQ: GNCMA) has expanded its presence in the Pacific Northwest, announcing today its acquisition of Northpoint Consulting LLC., a premier network consulting firm based in Seattle. The move positions GCI to provide broader management offerings nationwide, including unified communication, network security and cloud integration.

"We are thrilled to welcome Northpoint's team of network experts to the GCI family," said Martin Cary, senior vice president and general manager of GCI Business. "As we expand our footprint in the Pacific Northwest and across the nation, GCI will continue to recruit expert staff and invest in the latest technology in order to deliver the best possible solutions to our customers."

Northpoint provides consulting services like network analysis and security, cloud migration management and communications design, to many of the top Fortune 500 companies nationwide.

"GCI has been delivering services for more than 35 years and we're excited for Northpoint customers to be able to benefit from GCI's extensive portfolio," said Nathan Clark, founder of Northpoint. "We recognize the value of offering managed services to our customers to free up valuable resources and reduce costs."

As part of the acquisition, Clark will transition to vice president of business development in the Pacific Northwest for GCI and Northpoint's staff of 23 will become GCI employees.

About GCI
GCI delivers communication and technology services in the consumer and business markets. Headquartered in Alaska with additional locations in the U.S., GCI has delivered services for more than 35 years to some of the most remote communities and in some of the most challenging conditions in North America. Learn more about GCI at http://www.gci.com


Related Links


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.